J Vet Sci.
2005 Mar;6(1):81-82.
Cystic endometrial hyperplasia and endometritis in a dog following prolonged treatment of medroxyprogesterone acetate
Abstract
- An 8-year-old female Yorkshire Terrier was presented for investigation of reduced appetite, and occasional vomiting. She has been treated with medroxyprogesterone acetate (MPA) from past 3 year-old age for contraception. Abdominal sonography showed abnormal enlargement of uterus, and ovariohysterectomy was performed. Main gross findings of uterus were enlarged lesions in two areas of the left horn, which had thickened wall and yellowish sticky material in the lumen. Histopathologically, cystic endometrial hyperplasia (CEH) and endometritis were present in the thickened area. In this case, CEH and endometritis may be attributed to prolonged treatment of MPA. It was concluded that further study is needed to clarify the association of MPA treatment with age, its pathogenesis and abnormal uterine changes in dogs.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment of endometrial hyperplasia with Medroxyprogesterone acetate(MPA)
- In vitro respones of gynecological cancer cell lines to the GnRH agonist, medroxyprogesterone acetate and tamoxifen
- Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
- Marked Regression of Bilateral Pulmonary Metastases: Report of A Case Renal Cell Carcinoma after Nephrectomy and Medroxyprogesterone Acetate Therapy
- Treatment efficacy of high dose progestin in young women with early stage of endometrial carcinoma
